Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Friday, July 31, 2026.
Reported quarterly gross margin; no daily interpolation. Q1 FY2027 (2026-07-31): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
47.19%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$5.54M
Gross Margin
48.63%
TTM Avg
44.74%
3Y Avg
40.32%
5Y Avg
43.55%
Market Cap
$5.59M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.81M
Gross Margin
100.00%
TTM Avg
50.00%
3Y Avg
43.60%
5Y Avg
29.07%
Market Cap
$5.26M
Gross Margin
77.68%
TTM Avg
77.66%
3Y Avg
77.69%
5Y Avg
77.69%
Market Cap
$4.80M
Gross Margin
19.34%
TTM Avg
59.23%
3Y Avg
54.62%
5Y Avg
36.41%
Market Cap
$6.19M
Gross Margin
-1.29%
TTM Avg
-3.77%
3Y Avg
16.02%
5Y Avg
20.70%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alzamend Neuro Inc (ALZN) | $5.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| Imunon, Inc. (IMNN)vs › | $5.21M | 0.00% | 0.00% | 25.00% | 50.00% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.54M | 48.63% | 44.74% | 40.32% | 43.55% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.81M | 100.00% | 50.00% | 43.60% | 29.07% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.26M | 77.68% | 77.66% | 77.69% | 77.69% |
| CalciMedica, Inc. (CALC)vs › | $4.85M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.80M | 19.34% | 59.23% | 54.62% | 36.41% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.19M | -1.29% | -3.77% | 16.02% | 20.70% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.29M | 0.00% | 0.00% | 0.00% | -2.09% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-07-31 | 0.00% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | 0.00% |
| 2025-07-31 | 0.00% |
| 2025-04-30 | 0.00% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 0.00% |
| 2024-01-31 | 0.00% |
| 2023-10-31 | 0.00% |
| 2023-07-31 | 0.00% |
| 2023-04-30 | 0.00% |
| 2023-01-31 | 0.00% |
| 2022-10-31 | 0.00% |
| 2022-07-31 | 0.00% |
| 2022-04-30 | 0.00% |
| 2022-01-31 | 0.00% |
| 2021-10-31 | 0.00% |
| 2021-07-31 | 0.00% |
| 2021-04-30 | 0.00% |
| 2021-01-31 | 0.00% |
| 2020-10-31 | 0.00% |
| 2020-07-31 | 0.00% |
| 2020-04-30 | 0.00% |
| 2020-01-31 | 0.00% |
| 2019-10-31 | 0.00% |
| 2019-07-31 | 0.00% |
| 2019-04-30 | 0.00% |
| 2019-01-31 | 0.00% |
| 2018-10-31 | 0.00% |
| 2018-07-31 | 0.00% |
| 2018-04-30 | 0.00% |
| 2018-01-31 | 0.00% |
| 2017-10-31 | 0.00% |
| 2017-07-31 | 0.00% |
| 2017-04-30 | 50.00% |
| 2017-01-31 | 50.00% |
| 2016-10-31 | 0.00% |
| 2016-07-31 | 0.00% |
